Praxsys Biosystems Inc.
This article was originally published in Start Up
Praxsys's ReLIA is a simple, accurate point-of-care system for running sophisticated diagnostic tests -- including for hypothyroidism and routine, high-margin Ob/Gyn tests -- within the timeframe of an office visit to the physician. It is a next-generation immunoassay platform designed for ease of use and rapid output of results with the precision, accuracy, and reliability of central-laboratory tests.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.